Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...
Compounded weight-loss medications such as those promoted in the Hims & Hers commercial aren’t approved by the Food and Drug ...
Shares of Hims & Hers Health ( HIMS -24.30%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost ...
Leerink notes that the shortage of Novo Nordisk’s (NVO) semaglutide, marketed as Wegovy and Ozempic, has been resolved according to the FDA.
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
Lizzo has opened up about her weight loss journey by sharing updates with her fans on social media. However, the "Good as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback